IBEX 35
11.105,50 +55,40 (+0,50%) Euro Stoxx 50
5.085,08 +30,67 (+0,61%) Dólar/Euro
1,0772 -0,0012 (-0,11%) Petróleo Brent
82,79 -1,09 (-1,30%) Oro
2.375,00 +34,70 (+1,48%) Bitcoin EUR
56.926,07 +361,35 (+0,64%)
Panacos Pharmaceuticals, Inc. (PANC)
Panacos Pharmaceuticals, Inc.
134 Coolidge Avenue
Watertown, MA 02472
United States
617 926 1551
Sector(es):
Sector:
Empleados a tiempo completo: 41
Descripción
Panacos Pharmaceuticals, Inc., a development stage biotechnology company, engages in the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases. The company's discovery technologies focus on novel targets in the virus life cycle, including virus maturation and virus fusion. Its product pipeline includes second- and third-generation programs in HIV maturation inhibition. The company was founded in 1999 and is headquartered in Watertown, Massachusetts.
Gobierno corporativo
El ISS Governance QualityScore de Panacos Pharmaceuticals, Inc., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.
